FIELD: medicine. SUBSTANCE: the present method deals with peroral introduction of pharmaceutical agents which are poorly absorbed out of gastrointestinal tract. The method, also, deals with either elimination or decrease of hypersensitivity or allergic reactions in a patient on taxane-therapy, at treating diseases by taxane including peroral combined introduction of taxane and agent enhancing bioavailability in case of peroral intake without preliminary introduction of medicinal preparation to exclude hypersensitivity or allergic reactions, moreover, taxane reaches therapeutically active levels in a patient. EFFECT: higher bioavailability of the preparation suggested. 52 cl, 4 dwg
